Lepu Medical Technology Beijing Co Stock

Lepu Medical Technology Beijing Co Equity 2024

Lepu Medical Technology Beijing Co Equity

15.98 B CNY

Ticker

300003.SZ

ISIN

CNE100000H44

In 2024, Lepu Medical Technology Beijing Co's equity was 15.98 B CNY, a 5.48% increase from the 15.15 B CNY equity in the previous year.

Lepu Medical Technology Beijing Co Aktienanalyse

What does Lepu Medical Technology Beijing Co do?

Lepu Medical Technology Beijing Co Ltd was founded in 1999 and is a China-based company specializing in medical devices. The company is headquartered in Beijing and has branches and partners in over 70 countries worldwide. Business Model Lepu Medical's business model is based on the development, production, and distribution of medical devices and consumables. The company is divided into various divisions operating in the field of medical technology, including Cardiovascular, Neurovascular, Structural Heart, Peripheral Vascular, Interventional Oncology, and Infection Control. Products Lepu's products include a wide range of medical devices and consumables for various medical fields. In the Cardiovascular field, the company offers stents, balloon catheters, guide catheters, and vascular closure devices for peripheral vessels, cardiac surgery, and interventional cardiology. In the Neurovascular field, the company provides devices for the treatment of strokes that can dissolve blood clots in the brain. In the Structural Heart field, the company offers pericardial closure systems for minimally invasive treatment of heart defects. The Peripheral Vascular field includes devices for the treatment of diseases in other vessels in the body, such as the legs. Interventional Oncology involves devices for the treatment of cancer through targeted injection of chemotherapy or radioisotopes directly into the tumor. The Infection Control division includes medical devices and consumables for preventing infections during surgical procedures. History Lepu Medical Technology Beijing Co Ltd was founded in 1999 as a distributor of medical devices and consumables. In subsequent years, Lepu developed its own medical devices, laying the foundation for the company's success. In 2009, the company went public on the Shenzhen Stock Exchange. In the same year, Lepu introduced its first newly developed product, a stent for the treatment of peripheral vascular disease, to the Chinese market. Since then, Lepu Medical Technology Beijing Co Ltd has driven continuous expansion through product optimization and strategic acquisitions. Conclusion Lepu Medical Technology Beijing Co Ltd has established itself in the market for medical devices and consumables through its innovative products and constant expansion. The company is divided into various divisions specializing in specific medical fields. The wide range of products offered by the company has made it a significant player in the international market. Lepu Medical Technology Beijing Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Lepu Medical Technology Beijing Co's Equity

Lepu Medical Technology Beijing Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Lepu Medical Technology Beijing Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Lepu Medical Technology Beijing Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Lepu Medical Technology Beijing Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Lepu Medical Technology Beijing Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Lepu Medical Technology Beijing Co stock

What is the equity of Lepu Medical Technology Beijing Co this year?

Lepu Medical Technology Beijing Co has equity of 15.98 B CNY this year.

What was the equity of Lepu Medical Technology Beijing Co compared to the previous year?

The equity of Lepu Medical Technology Beijing Co has increased/decreased by 5.48% increased compared to the previous year.

What impact does a high equity have on investors of Lepu Medical Technology Beijing Co?

A high equity is advantageous for investors of Lepu Medical Technology Beijing Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Lepu Medical Technology Beijing Co?

A low equity can be a risk for investors of Lepu Medical Technology Beijing Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Lepu Medical Technology Beijing Co affect the company?

An increase in equity of Lepu Medical Technology Beijing Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Lepu Medical Technology Beijing Co affect the company?

A reduction in equity of Lepu Medical Technology Beijing Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Lepu Medical Technology Beijing Co?

Some factors that can affect the equity of Lepu Medical Technology Beijing Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Lepu Medical Technology Beijing Co so important for investors?

The equity of Lepu Medical Technology Beijing Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Lepu Medical Technology Beijing Co take to change the equity?

To change equity, Lepu Medical Technology Beijing Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Lepu Medical Technology Beijing Co pay?

Over the past 12 months, Lepu Medical Technology Beijing Co paid a dividend of 0.34 CNY . This corresponds to a dividend yield of about 2.6 %. For the coming 12 months, Lepu Medical Technology Beijing Co is expected to pay a dividend of 0.38 CNY.

What is the dividend yield of Lepu Medical Technology Beijing Co?

The current dividend yield of Lepu Medical Technology Beijing Co is 2.6 %.

When does Lepu Medical Technology Beijing Co pay dividends?

Lepu Medical Technology Beijing Co pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Lepu Medical Technology Beijing Co?

Lepu Medical Technology Beijing Co paid dividends every year for the past 17 years.

What is the dividend of Lepu Medical Technology Beijing Co?

For the upcoming 12 months, dividends amounting to 0.38 CNY are expected. This corresponds to a dividend yield of 2.89 %.

In which sector is Lepu Medical Technology Beijing Co located?

Lepu Medical Technology Beijing Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lepu Medical Technology Beijing Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lepu Medical Technology Beijing Co from 6/27/2024 amounting to 0.331 CNY, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Lepu Medical Technology Beijing Co pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Lepu Medical Technology Beijing Co in the year 2023?

In the year 2023, Lepu Medical Technology Beijing Co distributed 0.275 CNY as dividends.

In which currency does Lepu Medical Technology Beijing Co pay out the dividend?

The dividends of Lepu Medical Technology Beijing Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lepu Medical Technology Beijing Co

Our stock analysis for Lepu Medical Technology Beijing Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lepu Medical Technology Beijing Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.